Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Caribou Biosciences Inc
CRBUCurrent price
2.21 USD
+0.01 USD (+0.45%)
Last closed
1.96 USD
Company
cariboubio.com
ISIN
US1420381089
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
173 496 464 USD
Yield for 12 month
-47.13 %
1Y
3Y
5Y
10Y
15Y
CRBU
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California. Address: 2929 7th Street, Berkeley, CA, United States, 94710
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.63 USDP/E ratio
–Dividend Yield
–Current Year
+34 477 000 USD
Last Year
+13 851 000 USD
Current Quarter
+3 464 000 USD
Last Quarter
+2 429 000 USD
Current Year
+30 952 000 USD
Last Year
+10 210 000 USD
Current Quarter
+2 608 000 USD
Last Quarter
+1 719 000 USD
Key Figures CRBU
1 year
3 years
5 years
10 years
EBITDA
-137 692 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.49 %
PEG Ratio
–
Return On Equity TTM
-42.57 %
Wall Street Target Price
15.63 USD
Revenue TTM
33 113 000 USD
Book Value
3.44 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-7.8 %
Dividend Yield
–
Gross Profit TTM
-68 379 000 USD
Earnings per share
-1.32 USD
Diluted Eps TTM
-1.32 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CRBU
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CRBU
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CRBU
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
112.7254
Price Sales TTM
5.2395
Enterprise Value EBITDA
-36.9426
Price Book MRQ
0.5152
Financials CRBU
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CRBU
For 52 weeks
1.5 USD
8.33 USD
50 Day MA
1.98 USD
Shares Short Prior Month
11 672 513
200 Day MA
3.53 USD
Short Ratio
14.05
Shares Short
11 510 503
Short Percent
13.35 %
BeatStart